Publication Results (1303)

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• »

• Are income-based differences in TKA use and outcomes reduced in a single-payer system? A large-database comparison of the United States and Canada

  Mehta B, Ho K, Ling V, Goodman S, Parks M, Ravi B, Banerjee S, Wang F, Ibrahim S, Cram P. Clin Orthop Relat Res. 2022; May 9 [Epub ahead of print]. DOI: https://doi.org/10.1097/CORR.0000000000002207

• A population-based study evaluating retention in rheumatology care among patients with rheumatoid arthritis

  Barber CEH, Lacaille D, Croxford R, Barnabe C, Marshall DA, Abrahamowicz M, Xie H, Avina-Zubieta JA, Esdaile JM, Hazlewood G, Faris P, Katz S, MacMullan P, Mosher D, Widdifield J. ACR Open Rheumatol. 2022; May 5 [Epub ahead of print]. DOI: https://doi.org/10.1002/acr2.11442

• "Bring the hoses to where the fire is!": differential impacts of marginalization and socioeconomic status on COVID-19 case counts and healthcare costs

  Cheung DC, Bremner KE, Tsui TCO, Croxford R, Lapointe-Shaw L, Del Giudice L, Mendlowitz A, Perlis N, Pataky RE, Teckle P, Zeitouny S, Wong WWL, Sander B, Peacock S, Krahn MD, Kulkarni GS, Mulder C. Value Health. 2022; May 5 [Epub ahead of print]. DOI: https://doi.org/10.1016/j.jval.2022.03.019

• Evaluation of bronchiolitis-related emergency department visits from 2004 to 2018: a population-based cohort study

  Brunet J, Gill PJ, Imsirovic H, Parkin PC, To T, Schuh S, Mahant S; Canadian Paediatric Inpatient Research Network (PIRN). JAMA Pediatr. 2022; May 2 [Epub ahead of print]. DOI: https://doi.org/10.1001/jamapediatrics.2022.0707

• Access to hip arthroplasty and rates of complications in different socioeconomic groups : a review of 111,000 patients in a universal healthcare system

  Atrey A, Pincus D, Khoshbin A, Haddad FS, Ward S, Aktar S, Ladha K, Ravi B. Bone Joint J. 2022; 104-B(5):589-97. Epub 2022 May 1. DOI: https://doi.org/10.1302/0301-620X.104B5.BJJ-2021-1520.R2< a>

• Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance

  Nasreen S, Calzavara A, Buchan SA, Thampi N, Johnson C, Wilson SE, Kwong JC; on behalf of the Canadian Immunization Research Network CIRN Provincial Collaborative Network PCN Ontario investigators. Vaccine. 2022; 40(24):3305-12. Epub 2022 Apr 27. DOI: https://doi.org/10.1016/j.vaccine.2022.04.065

• Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: a population-based study

  Antoniou T, Men S, Tadrous M, Leece P, Munro C, Gomes T. Drug Alcohol Depend. 2022; 236:109473. Epub 2022 Apr 26. DOI: https://doi.org/10.1016/j.drugalcdep.2022.109473

• Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: a population-based time series analysis

  Garg R, Kitchen SA, Men S, Campbell TJ, Bozinoff N, Tadrous M, Antoniou T, Wyman J, Werb D, Munro C, Gomes T. Drug Alcohol Depend. 2022; 236:109459. Epub 2022 Apr 14. DOI: https://doi.org/10.1016/j.drugalcdep.2022.109459

• Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis

  Widdifield J, Kwong JC, Chen S, Eder L, Benchimol EI, Kaplan GG, Hitchon C, Aviña-Zubieta JA, Lacaille D, Chung H, Bernatsky S. Lancet Rheumatol. 2022; Apr 14 [Epub ahead of print]. DOI: https://doi.org/10.1016/S2665-9913(22)00096-0

• Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions

  Bouck Z, Scheimac AI, Gomes T, Ling V, Caudarella A, Werb D. Int J Drug Policy. 2022; 104:103680. Epub 2022 Apr 13. DOI: https://doi.org/10.1016/j.drugpo.2022.103680

• Regional differences in access to direct-acting antiviral treatments for hepatitis C across Ontario: a cross-sectional study

  Konstantelos N, Shakeri A, McCormack D, Campos-Meade A, Gomes T, Murti M, Pierre-Pierre V, Tadrous M. Can Commun Dis Rep. 2022; 48(4):170-8. Epub 2022 Apr 1. DOI: https://doi.org/10.14745/ccdr.v48i04a08

• The risk of ventricular dysrhythmia or sudden death in patients receiving serotonin reuptake inhibitors with methadone: a population-based study

  Antoniou T, McCormack D, Tadrous M, Juurlink DN, Gomes T. Front Pharmacol. 2022; 13:861953. Epub 2022 Mar 11. DOI: https://doi.org/10.3389/fphar.2022.861953

• Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study

  Gomes T, McCormack D, Bozinoff N, Tadrous M, Antoniou T, Munro C, Campbell T, Paterson JM, Mamdani M, Sproule B. Addiction. 2022; Mar 8 [Epub ahead of print]. DOI: https://doi.org/10.1111/add.15862

• Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation

  Gomes T, Campbell TJ, Kitchen SA, Garg R, Bozinoff N, Men S, Tadrous M, Munro C, Antoniou T, Werb D, Wyman J. JAMA. 2022; 327(9):846-55. Epub 2022 Mar 1. DOI: https://doi.org/10.1001/jama.2022.1271

• Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: a population-based time-series analysis

  Kitchen SA, Campbell TJ, Men S, Bozinoff N, Tadrous M, Antoniou T, Wyman J, Werb D, Munro C, Gomes T. Int J Drug Policy. 2022; 103:103644. Epub 2022 Mar 1. DOI: https://doi.org/10.1016/j.drugpo.2022.103644

• Bariatric surgery and breast cancer incidence: a population-based, matched cohort study

  Doumouras AG, Lovrics O, Paterson JM, Sutradhar R, Paszat L, Sivapathasundaram B, Tarride J, Anvari M. Obes Surg. 2022; 32(4):1261-9. Epub 2022 Feb 25. DOI: https://doi.org/10.1007/s11695-022-05946-9

• Evaluation of definitions for oral anticoagulant-associated major bleeding: a population-based cohort study

  Xu Y, Gomes T, Wells PS, Pequeno P, Johnson A, Sholzberg M. Thromb Res. 2022; 213:57-64. Epub 2022 Feb 23. DOI: https://doi.org/10.1016/j.thromres.2022.02.018

• Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada

  Kuenzig ME, Widdifield J, Bernatsky S, Kaplan GG, Benchimol EI. Lancet Gastroenterol Hepatol. 2022; 7(4):288-9. Epub 2022 Feb 22. DOI: https://doi.org/10.1016/S2468-1253(22)00054-1

• Perioperative opioid-prescribing practices of resident trainees compared with staff surgeons

  Murji A, Richard L, McArthur E, Austin PC, Lipscombe L, Gomes T. Am J Obstet Gynecol. 2022; 226(6):859-60.e2. Epub 2022 Feb 12. DOI: https://doi.org/10.1016/j.ajog.2022.02.011

• Prevalence, cost, and variation in cost of pediatric hospitalizations in Ontario, Canada

  Gill PJ, Thavam T, Anwar MR, Zhu J, Parkin PC, Cohen E, To T, Mahant S; for the Ontario Pediatric Hospital Care Study Group (OPHCSG) and the Canadian Paediatric Inpatient Research Network (PIRN). JAMA Netw Open. 2022; 5(2):e2147447. Epub 2022 Feb 9. DOI: https://doi.org/10.1001/jamanetworkopen.2021.47447

• Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada

  Young S, Koll G, McCormack D, Campbell T, Leece P, Strike C, Srivastava A, Antoniou T, Bayoumi AM, Gomes T. Int J Drug Policy. 2022; 102:103601. Epub 2022 Feb 3. DOI: https://doi.org/10.1016/j.drugpo.2022.103601

• COVID-19 hospitalizations, intensive care unit stays, ventilation and death among patients with immune mediated inflammatory diseases compared to controls

  Eder L, Croxford R, Drucker AM, Mendel A, Kuriya B, Touma Z, Johnson SR, Cook R, Bernatsky S, Haroon N, Widdifield J. J Rheumatol. 2022; 49(5):523-30. Epub 2022 Feb 1. DOI: https://doi.org/10.3899/jrheum.211012

• Is overreliance on short-acting β2-agonists associated with health risks in the older asthma population?

  To T, Zhu J, Terebessy E, Zhang K, Gershon AS, Licskai C. ERJ Open Res. 2022; 8(1):00032-02022. Epub 2022 Feb 1. DOI: https://doi.org/10.1183/23120541.00032-2022

• Association of material deprivation with discharge location and length of stay after inpatient stroke rehabilitation in Ontario: a retrospective, population-based cohort study

  MacDonald SL, Hall RE, Bell CM, Cronin S, Jaglal SB. CMAJ Open. 2022; 10(1):E50-5. Epub 2022 Jan 25. DOI: https://doi.org/10.9778/cmajo.20200300

• Using health administrative data to identify patients with pulmonary hypertension: a single center, proof of concept validation study in Ontario, Canada

  Wijeratne DT, Housin A, Lajkosz K, Lougheed MD, Xiong PY, Barber D, Doliszny KM, Archer SL. Pulm Circ. 2022; 12(1):e12040. Epub 2022 Jan 24. DOI: https://doi.org/10.1002/pul2.12040

• COVID-19 vaccination uptake among individuals with immune-mediated inflammatory diseases in Ontario, Canada between December 2020 and October 2021: a population-based analysis

  Widdifield J, Eder L, Chen S, Kwong JC, Hitchon C, Lacaille D, Aviña-Zubieta JA, Svenson LW, Bernatsky S. J Rheumatol. 2022; 49(5):531-6. Epub 2022 Jan 15. DOI: https://doi.org/10.3899/jrheum.211148

• Trends in non-receipt of recommended chronic obstructive pulmonary disease medication

  Poon M, Pequeno P, Aaron SD, Stanbrook M, Wong H, Cram P, Gershon AS. ERJ Open Res. 2022; 25(2):00584-02021. Epub 2022 Jan 13. DOI: https://doi.org/10.1183/23120541.00584-2021

• Comparative fracture risk during osteoporosis drug holidays after long-term risedronate versus alendronate therapy: a propensity score-matched cohort study

  Hayes KN, Brown KA, Cheung AM, Kim SA, Juurlink DN, Cadarette SM. Ann Intern Med. 2022; 175(3):335-43. Epub 2022 Jan 11. DOI: https://doi.org/10.7326/M21-2512

• The adverse cardiovascular risk factor profile of women with pre-eclampsia develops over time in the years before pregnancy

  Retnakaran R, Shah BR. BJOG. 2021; Dec 26 [Epub ahead of print]. DOI: https://doi.org/10.1111/1471-0528.17084

• Rates in bronchiolitis hospitalization, intensive care unit use, mortality, and costs from 2004 to 2018

  Mahant S, Parkin PC, Thavam T, Imsirovic H, Tuna M, Knight B, Webster R, Schuh S, To T, Gill PJ; for the Canadian Paediatric Inpatient Research Network (PIRN). JAMA Pediatr. 2022; 176(2):e215177. Epub 2021 Dec 20. DOI: https://doi.org/10.1001/jamapediatrics.2021.5177

• The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis

  Boone CG, Antoniou T, Juurlink DN, von den Baumen TR, Kitchen SA, Richards GC, Tadrous M, Gomes T. CMAJ Open. 2021; 9(4):E1181-6. Epub 2021 Dec 14. DOI: https://doi.org/10.9778/cmajo.20210173

• Fracture profiles of a 4-year cohort of 266,324 first incident upper extremity fractures from population health data in Ontario

  MacDermid JC, McClure JA, Richard L, Faber KJ, Jaglal S. BMC Musculoskelet Disord. 2021; 22(1):996. Epub 2021 Nov 29. DOI: https://doi.org/10.1186/s12891-021-04849-7

• Comparison of claims from high-drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis

  Tadrous M, Daniels B, Pearson S, Gomes T. CMAJ Open. 2021; 9(4):E1048-54. Epub 2021 Nov 23. DOI: https://doi.org/10.9778/cmajo.20200291

• Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis

  Gomes T, McCormack D, Kitchen SA, Paterson JM, Mamdani MM, Proulx L, Bayliss L, Tadrous M. CMAJ Open. 2021; 9(4):E1055-62. Epub 2021 Nov 23. DOI: https://doi.org/10.9778/cmajo.20210091

• Polysomnographic markers of obstructive sleep apnea severity and cancer-related mortality: a large retrospective multicenter clinical cohort study

  Kendzerska T, Gershon AS, Povitz M, Boulos MI, Murray BJ, McIsaac DI, Bryson GL, Talarico R, Hilton J, Malhotra A, Leung RS. Ann Am Thorac Soc. 2022; 19(5):807-18. Epub 2021 Nov 17. DOI: https://doi.org/10.1513/AnnalsATS.202106-738OC

• Validation of self-reported opioid agonist treatment among people who inject drugs using prescription dispensation records

  Bouck Z, Tricco AC, Rosella LC, Ling V, Gomes T, Tadrous M, Fox MP, Scheim AI, Werb D. Epidemiology. 2022; 33(2):287-94. Epub 2021 Nov 12. DOI: https://doi.org/10.1097/EDE.0000000000001443

• New opioid use and risk of emergency department visits related to motor vehicle collisions in Ontario, Canada

  Guan Q, McCormack D, Juurlink DN, Bronskill SE, Wunsch H, Gomes T. JAMA Netw Open. 2021; 4(11):e2134248. Epub 2021 Nov 11. DOI: https://doi.org/10.1001/jamanetworkopen.2021.34248

• Patterns of pre-operative opioid use affect the risk for complications after total joint replacement

  Ravi B, Pincus D, Croxford R, Leroux T, Paterson JM, Hawker G, Redelmeier DA. Sci Rep. 2021; 11(1):22124. Epub 2021 Nov 11. DOI: https://doi.org/10.1038/s41598-021-01179-5

• Language proficiency and warfarin-related adverse events in older immigrants and Canadian residents: a population-based cohort study

  Wijeratne DT, Okarinec K, Gomes T, Martins D, Mamdani MM, Rochon PA, Evans GA, Gill SS. Drugs Ther Perspect. 2021; 37(12):590-8. Epub 2021 Nov 10. DOI: https://doi.org/10.1007/s40267-021-00877-4

• Receipt of overactive bladder drugs and incident dementia: a population-based case-control study

  Matta R, Gomes T, Juurlink D, Jarvi K, Herschorn S, Nam, RK. Eur Urol Focus. 2021; Nov 3 [Epub ahead of print]. DOI: https://doi.org/10.1016/j.euf.2021.10.009

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• »